← back to search

F. Nina Papavasiliou

German Cancer Research Center · DE
Area of research
Molecular Biology · Immunology
Research interest
Research interests include Trypanosoma species research and implications, RNA regulation and disease, T-cell and B-cell Immunology, and Immune Cell Function and Interaction.
h-index
45
citations
10,459
works
113
NIH funding
primary concept
email

Recent publications

DGAT1 mediates sex-specific CD8+ T cell antitumour responses
Nature Metabolism 2026cited by 2position: middledoi
Serine enrichment in tumors promotes regulatory T cell accumulation through sphinganine-mediated regulation of c-Fos
Science Immunology 2024cited by 44position: middledoi
APOBEC2 safeguards skeletal muscle cell fate through binding chromatin and regulating transcription of non-muscle genes during myoblast differentiation
Proceedings of the National Academy of Sciences 2024cited by 10position: lastdoi
The fentanyl-specific antibody FenAb024 can shield against carfentanil effects
Toxicology Letters 2024cited by 5position: middledoi
ADAR1-mediated RNA editing promotes B cell lymphomagenesis
iScience 2023cited by 24position: middledoi
A trypanosome-derived immunotherapeutics platform elicits potent high-affinity antibodies, negating the effects of the synthetic opioid fentanyl
Cell Reports 2023cited by 17position: middledoi
Immunodominant surface epitopes power immune evasion in the African trypanosome
Cell Reports 2023cited by 14position: lastdoi
A structural classification of the variant surface glycoproteins of the African trypanosome
PLoS neglected tropical diseases 2023cited by 14position: middledoi
ADAR RNA editing on antisense RNAs results in apparent U-to-C base changes on overlapping sense transcripts
Frontiers in Cell and Developmental Biology 2023cited by 9position: lastdoi
Structural similarities between the metacyclic and bloodstream form variant surface glycoproteins of the African trypanosome
PLoS neglected tropical diseases 2023cited by 8position: middledoi
A Structural Classification of the Variant Surface Glycoproteins of the African Trypanosome
bioRxiv (Cold Spring Harbor Laboratory) 2023cited by 2position: middledoi
Employing RNA editing to engineer personalized tumor-specific neoantigens (editopes)
bioRxiv (Cold Spring Harbor Laboratory) 2023cited by 2position: lastdoi
Functions and consequences of AID/APOBEC-mediated DNA and RNA deamination
Nature Reviews Genetics 2022cited by 258position: lastdoi
Rapid, adaptable and sensitive Cas13-based COVID-19 diagnostics using ADESSO
Nature Communications 2022cited by 75position: middledoi
RNA Editing Alterations Define Disease Manifestations in the Progression of Experimental Autoimmune Encephalomyelitis (EAE)
Cells 2022cited by 11position: middledoi
Immunization with Genetically Modified Trypanosomes Provides Protection against Transmissible Spongiform Encephalopathies
International Journal of Molecular Sciences 2022cited by 2position: middledoi
An Epitope-Focused Trypanosome-Derived Vaccine Platform Elicits High-Affinity Antibodies and Immunity Against Fentanyl Effects
bioRxiv (Cold Spring Harbor Laboratory) 2022cited by 1position: middledoi
Acute expression of human APOBEC3B in mice causes lethality associated with RNA editing
Research Square 2022cited by 1position: middledoi
SARS-CoV-2 variant evolution in the United States: High accumulation of viral mutations over time likely through serial Founder Events and mutational bursts
PLoS ONE 2021cited by 38position: middledoi
Structure of trypanosome coat protein VSGsur and function in suramin resistance
Nature Microbiology 2021cited by 33position: middledoi
Harnessing self-labeling enzymes for selective and concurrent A-to-I and C-to-U RNA base editing
Nucleic Acids Research 2021cited by 30position: middledoi
Nanobody-mediated macromolecular crowding induces membrane fission and remodeling in the African trypanosome
Cell Reports 2021cited by 17position: middledoi
SARS-CoV-2 variant evolution in the United States: High accumulation of viral mutations over time likely through serial Founder Events and mutational bursts
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 8position: middledoi
Immunodominant surface epitopes power immune evasion in the African trypanosome
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 6position: lastdoi
ADESSO: a rapid, adaptable and sensitive Cas13-based COVID-19 diagnostic platform
medRxiv 2021cited by 3position: middledoi
Nanobody Mediated Macromolecular Crowding Induces Membrane Fission and Remodeling in the African Trypanosome
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 1position: middledoi
CYTIDINE DEAMINASES SHAPE THE GENOME OF GERMINAL CENTER B CELL DERIVED LYMPHOMA
Hematological Oncology 2021cited by 0position: middledoi
C-to-U RNA Editing: From Computational Detection to Experimental Validation
Methods in molecular biology 2020cited by 12position: middledoi
ADAR1 can drive Multiple Myeloma progression by acting both as an RNA editor of specific transcripts and as a DNA mutator of their cognate genes
bioRxiv (Cold Spring Harbor Laboratory) 2020cited by 7position: lastdoi
APOBEC2 is a Transcriptional Repressor required for proper Myoblast Differentiation
bioRxiv (Cold Spring Harbor Laboratory) 2020cited by 4position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

C. Erec Stebbins · German Cancer Research Center16 papers (2018–2024)Joseph Verdi · The Graduate Center, CUNY11 papers (2018–2024)Monique van Straaten · German Cancer Research Center10 papers (2020–2023)Johan Zeelen · German Cancer Research Center9 papers (2020–2023)Rafail Nikolaos Tasakis · Icahn School of Medicine at Mount Sinai8 papers (2019–2022)Riccardo Pecori · German Cancer Research Center8 papers (2018–2023)Francisco Aresta‐Branco · German Cancer Research Center7 papers (2018–2023)Hamidreza Hashemi · Legambiente6 papers (2020–2023)Anastasia Gkeka · German Cancer Research Center6 papers (2021–2024)Evi P. Vlachou · European Molecular Biology Laboratory6 papers (2021–2023)A. Hempelmann · Heidelberg Pharma (Germany)6 papers (2020–2022)Sandra Ruf · German Cancer Research Center5 papers (2020–2024)Monica Chandra · Heidelberg University5 papers (2023–2024)Gianna Triller · Cancer Research Center5 papers (2021–2023)Violeta Rayon-Estrada · Massachusetts Institute of Technology4 papers (2017–2019)Dewi Harjanto · Fidelity Biosciences (United States)4 papers (2017–2024)Kathryn Perez · California Institute of Technology4 papers (2020–2023)Sara Đaković · German Cancer Research Center3 papers (2023–2023) · 3 papers (2022–2024)Mirjana Lilić · Rockefeller University3 papers (2018–2023)